Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
Identifieur interne : 001687 ( Main/Exploration ); précédent : 001686; suivant : 001688Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
Auteurs : Huifeng Yun ; Fenglong Xie ; Randall N. Beyl ; Lang Chen ; James D. Lewis [États-Unis] ; Kenneth G. Saag ; Jeffrey R. CurtisSource :
- Arthritis care & research [ 2151-4658 ] ; 2017.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antirhumatismaux (effets indésirables), Bases de données factuelles, Données administratives des demandes de remboursement des soins de santé, Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs), Facteur de nécrose tumorale alpha (immunologie), Facteurs de risque, Facteurs temps, Femelle, Humains, Hypersensibilité médicamenteuse (diagnostic), Hypersensibilité médicamenteuse (épidémiologie), Incidence, Medicare (USA), Mâle, Polyarthrite rhumatoïde (diagnostic), Polyarthrite rhumatoïde (immunologie), Polyarthrite rhumatoïde (traitement médicamenteux), Produits biologiques (effets indésirables), Sujet âgé, Sujet âgé de 80 ans ou plus, États-Unis d'Amérique (épidémiologie), Études rétrospectives, Évaluation des risques.
- MESH :
- antagonistes et inhibiteurs : Facteur de nécrose tumorale alpha.
- diagnostic : Hypersensibilité médicamenteuse, Polyarthrite rhumatoïde.
- effets indésirables : Antirhumatismaux, Produits biologiques.
- immunologie : Facteur de nécrose tumorale alpha, Polyarthrite rhumatoïde.
- traitement médicamenteux : Polyarthrite rhumatoïde.
- épidémiologie : Hypersensibilité médicamenteuse, États-Unis d'Amérique.
- Adulte d'âge moyen, Bases de données factuelles, Données administratives des demandes de remboursement des soins de santé, Facteurs de risque, Facteurs temps, Femelle, Humains, Incidence, Medicare (USA), Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives, Évaluation des risques.
English descriptors
- KwdEn :
- Administrative Claims, Healthcare, Aged, Aged, 80 and over, Antirheumatic Agents (adverse effects), Arthritis, Rheumatoid (diagnosis), Arthritis, Rheumatoid (drug therapy), Arthritis, Rheumatoid (immunology), Biological Products (adverse effects), Databases, Factual, Drug Hypersensitivity (diagnosis), Drug Hypersensitivity (epidemiology), Female, Humans, Incidence, Male, Medicare, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors, Tumor Necrosis Factor-alpha (antagonists & inhibitors), Tumor Necrosis Factor-alpha (immunology), United States (epidemiology).
- MESH :
- chemical , adverse effects : Antirheumatic Agents, Biological Products.
- chemical , antagonists & inhibitors : Tumor Necrosis Factor-alpha.
- diagnosis : Arthritis, Rheumatoid, Drug Hypersensitivity.
- drug therapy : Arthritis, Rheumatoid.
- epidemiology : Drug Hypersensitivity, United States.
- immunology : Arthritis, Rheumatoid, Tumor Necrosis Factor-alpha.
- Administrative Claims, Healthcare, Aged, Aged, 80 and over, Databases, Factual, Female, Humans, Incidence, Male, Medicare, Middle Aged, Retrospective Studies, Risk Assessment, Risk Factors, Time Factors.
Abstract
Hypersensitivity reactions (HSRs) can occur with any of the available biologic agents used to treat rheumatoid arthritis (RA). We compared drug-specific risks for HSRs among RA patients enrolled in the US Medicare program.
DOI: 10.1002/acr.23141
PubMed: 27813327
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D09
- to stream PubMed, to step Curation: 000D09
- to stream PubMed, to step Checkpoint: 000A74
- to stream Ncbi, to step Merge: 001378
- to stream Ncbi, to step Curation: 001378
- to stream Ncbi, to step Checkpoint: 001378
- to stream Main, to step Merge: 001686
- to stream Main, to step Curation: 001687
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.</title><author><name sortKey="Yun, Huifeng" sort="Yun, Huifeng" uniqKey="Yun H" first="Huifeng" last="Yun">Huifeng Yun</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Xie, Fenglong" sort="Xie, Fenglong" uniqKey="Xie F" first="Fenglong" last="Xie">Fenglong Xie</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Beyl, Randall N" sort="Beyl, Randall N" uniqKey="Beyl R" first="Randall N" last="Beyl">Randall N. Beyl</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Lewis, James D" sort="Lewis, James D" uniqKey="Lewis J" first="James D" last="Lewis">James D. Lewis</name><affiliation wicri:level="3"><nlm:affiliation>University of Pennsylvania, Philadelphia.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>University of Pennsylvania</wicri:orgArea></affiliation></author><author><name sortKey="Saag, Kenneth G" sort="Saag, Kenneth G" uniqKey="Saag K" first="Kenneth G" last="Saag">Kenneth G. Saag</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Curtis, Jeffrey R" sort="Curtis, Jeffrey R" uniqKey="Curtis J" first="Jeffrey R" last="Curtis">Jeffrey R. Curtis</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27813327</idno><idno type="pmid">27813327</idno><idno type="doi">10.1002/acr.23141</idno><idno type="wicri:Area/PubMed/Corpus">000D09</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D09</idno><idno type="wicri:Area/PubMed/Curation">000D09</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D09</idno><idno type="wicri:Area/PubMed/Checkpoint">000A74</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A74</idno><idno type="wicri:Area/Ncbi/Merge">001378</idno><idno type="wicri:Area/Ncbi/Curation">001378</idno><idno type="wicri:Area/Ncbi/Checkpoint">001378</idno><idno type="wicri:Area/Main/Merge">001686</idno><idno type="wicri:Area/Main/Curation">001687</idno><idno type="wicri:Area/Main/Exploration">001687</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.</title><author><name sortKey="Yun, Huifeng" sort="Yun, Huifeng" uniqKey="Yun H" first="Huifeng" last="Yun">Huifeng Yun</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Xie, Fenglong" sort="Xie, Fenglong" uniqKey="Xie F" first="Fenglong" last="Xie">Fenglong Xie</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Beyl, Randall N" sort="Beyl, Randall N" uniqKey="Beyl R" first="Randall N" last="Beyl">Randall N. Beyl</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Lewis, James D" sort="Lewis, James D" uniqKey="Lewis J" first="James D" last="Lewis">James D. Lewis</name><affiliation wicri:level="3"><nlm:affiliation>University of Pennsylvania, Philadelphia.</nlm:affiliation><country>États-Unis</country><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName><wicri:orgArea>University of Pennsylvania</wicri:orgArea></affiliation></author><author><name sortKey="Saag, Kenneth G" sort="Saag, Kenneth G" uniqKey="Saag K" first="Kenneth G" last="Saag">Kenneth G. Saag</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author><author><name sortKey="Curtis, Jeffrey R" sort="Curtis, Jeffrey R" uniqKey="Curtis J" first="Jeffrey R" last="Curtis">Jeffrey R. Curtis</name><affiliation><nlm:affiliation>University of Alabama at Birmingham.</nlm:affiliation><wicri:noCountry code="no comma">University of Alabama at Birmingham.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Arthritis care & research</title><idno type="eISSN">2151-4658</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administrative Claims, Healthcare</term><term>Aged</term><term>Aged, 80 and over</term><term>Antirheumatic Agents (adverse effects)</term><term>Arthritis, Rheumatoid (diagnosis)</term><term>Arthritis, Rheumatoid (drug therapy)</term><term>Arthritis, Rheumatoid (immunology)</term><term>Biological Products (adverse effects)</term><term>Databases, Factual</term><term>Drug Hypersensitivity (diagnosis)</term><term>Drug Hypersensitivity (epidemiology)</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Medicare</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Assessment</term><term>Risk Factors</term><term>Time Factors</term><term>Tumor Necrosis Factor-alpha (antagonists & inhibitors)</term><term>Tumor Necrosis Factor-alpha (immunology)</term><term>United States (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antirhumatismaux (effets indésirables)</term><term>Bases de données factuelles</term><term>Données administratives des demandes de remboursement des soins de santé</term><term>Facteur de nécrose tumorale alpha (antagonistes et inhibiteurs)</term><term>Facteur de nécrose tumorale alpha (immunologie)</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hypersensibilité médicamenteuse (diagnostic)</term><term>Hypersensibilité médicamenteuse (épidémiologie)</term><term>Incidence</term><term>Medicare (USA)</term><term>Mâle</term><term>Polyarthrite rhumatoïde (diagnostic)</term><term>Polyarthrite rhumatoïde (immunologie)</term><term>Polyarthrite rhumatoïde (traitement médicamenteux)</term><term>Produits biologiques (effets indésirables)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>États-Unis d'Amérique (épidémiologie)</term><term>Études rétrospectives</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antirheumatic Agents</term><term>Biological Products</term></keywords><keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Tumor Necrosis Factor-alpha</term></keywords><keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Drug Hypersensitivity</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hypersensibilité médicamenteuse</term><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antirhumatismaux</term><term>Produits biologiques</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Drug Hypersensitivity</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Tumor Necrosis Factor-alpha</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Hypersensibilité médicamenteuse</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administrative Claims, Healthcare</term><term>Aged</term><term>Aged, 80 and over</term><term>Databases, Factual</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Medicare</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Risk Assessment</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Bases de données factuelles</term><term>Données administratives des demandes de remboursement des soins de santé</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Medicare (USA)</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études rétrospectives</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Hypersensitivity reactions (HSRs) can occur with any of the available biologic agents used to treat rheumatoid arthritis (RA). We compared drug-specific risks for HSRs among RA patients enrolled in the US Medicare program.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region><settlement><li>Philadelphie</li></settlement></list><tree><noCountry><name sortKey="Beyl, Randall N" sort="Beyl, Randall N" uniqKey="Beyl R" first="Randall N" last="Beyl">Randall N. Beyl</name><name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name><name sortKey="Curtis, Jeffrey R" sort="Curtis, Jeffrey R" uniqKey="Curtis J" first="Jeffrey R" last="Curtis">Jeffrey R. Curtis</name><name sortKey="Saag, Kenneth G" sort="Saag, Kenneth G" uniqKey="Saag K" first="Kenneth G" last="Saag">Kenneth G. Saag</name><name sortKey="Xie, Fenglong" sort="Xie, Fenglong" uniqKey="Xie F" first="Fenglong" last="Xie">Fenglong Xie</name><name sortKey="Yun, Huifeng" sort="Yun, Huifeng" uniqKey="Yun H" first="Huifeng" last="Yun">Huifeng Yun</name></noCountry><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Lewis, James D" sort="Lewis, James D" uniqKey="Lewis J" first="James D" last="Lewis">James D. Lewis</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001687 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001687 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27813327
|texte= Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27813327" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |